Location of Repository

Synthesis of novel inhibitors of CDK 4 / Cyclin D1 based on the natural marine sponge pigment fascaplysin.

By Anthony James Wilson


This thesis describes an investigation into the design and synthesis of novel inhibitors of the cell-cycle regulatory enzyme CDK4/Cyclin D1 utilising the structure of the natural product fascaplysin as a lead compound.\ud The structure activity relationship of fascaplysin (i) has been investigated and its structure simplified and rationalised to give novel inhibitor pharmacophores based on structures (ii) and (iii). Inhibitors of structure (ii) were found to possess activity against CDK4/Cyclin D1 of IC50 51-176 μM and to be approximately 15-20 fold selective over CDK2/Cyclin A. The second generation compounds of structure (iii) were synthesised to explore a suspected π-stacking pocket in the active site of CDK4 around the Phe93 residue. These compounds were active against CDK4/Cyclin D1 with IC50 values in the range 7-50 μM and to be 20-100 fold selective over CDK2/Cyclin A.\ud New methodology towards the synthesis of un-natural products bearing a carbohydrate subunit connected via the anomeric 1-position and the 2- and 3- positions of the sugar was also explored. Indole was successfully glycosylated with a glucose subunit at the anomeric position (v) using the anhydrosugar (iv) and indoline was glycosylated with a glucose sugar derivative at the 3-position (viii) using the manno-epoxide (vi)

Publisher: University of Leicester
Year: 2009
OAI identifier: oai:lra.le.ac.uk:2381/4531

Suggested articles



  1. 165.4; m/z (ES+) 357 (MH+). N-(2-(1H-indol-3-yl)ethyl)-4-(benzyloxy)benzamide 70. Procedure B was followed. Oily white semi solid; 89 % yield;
  2. 5.1 Crystal structure data for D-glucal 95. Chapter Five: Experimental Data Chapter Five: Experimental Data Table 4. Anisotropic displacement parameters (Å2x 103) for 07022. The anisotropic displacement factor exponent takes the form:
  3. (1999). Annual Review of Pharmacology and Toxicology, doi
  4. (2003). Appendix One: References
  5. (2001). Biochemistry of Signal Transduction and Regulation Wiley-VCH, doi
  6. Biphenyl Inhibitors Chapter Five: Experimental Data N(10)H), 10.82
  7. (2003). Cell Proliferation, doi
  8. (2001). Chemistry- A European Journa, doi
  9. (1997). Clinical Cancer Research,
  10. (2002). Current Opinion in Chemical Biology, doi
  11. (2003). Current Opinion in Pharmacology, doi
  12. De Assis, doi
  13. (2003). Drug Resistance Update, doi
  14. (1989). Fetus into Man,
  15. (1991). HeIvetica Chimica Acta,
  16. (2006). Heterocycles, doi
  17. Introduction to Cellular Signal Transduction, doi
  18. m, Indoline C(2)H), 3.83 (1H, t, 10.4, C(6ax)H), 4.24 (1H, br-s, C(3)H), 4.28-4.34
  19. (2001). Molecular Pharmacology,
  20. (2002). Science, doi
  21. (2001). Scientific American, doi
  22. (1974). Synthesis, doi
  23. (2001). Tetrahedron: Asymmetry, doi
  24. The Cell Cycle: Principles of Control, doi
  25. (1997). Topics in Catalysis, doi
  26. (1977). Trends in Biochemical Sciences, doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.